With more than 600k average monthly users on the HotCopper forums, each and every discussion can move markets. That’s why getting in front of those red-hot trends is key for every trader worth their salt.
.png)
In this daily HotCopper Trends column, we break down the top Oz stocks through each trading day.
IMM | Positive clinical data drives investor interest
Immutep (ASX: IMM) was up after it announced positive data from its phase one study of IMP761, its first-in-class LAG-3 agonist antibody.
The ongoing phase one study is a randomised, placebo-controlled, double-blind first-in-human study being conducted by the Centre for Human Drug Research (CHDR) in Leiden, the Netherlands, evaluating IMP761 in healthy volunteers using the keyhole limpet haemocyanin (KLH) challenge model.
“These results derived from a large double- blinded trial clearly show the immunosuppressive effect of IMP761 on a strong antigen-driven T-cell response in tissues, without safety concerns,” CEO, Dr Frédéric Triebel, said.
“After this challenging proof-of-concept in healthy participants, we are now confident that direct T-cell receptor inhibition through LAG- 3 agonism opens a new frontier in the treatment of autoimmune patients where the root cause of the disease is mainly driven by the overreaction of a few weak-affinity self-peptide- reactive pathogenic T cells that should be controlled by IMP761.”
NMR | Charters Towers joint venture sparks investor interest
Native Mineral Resources (ASX: NMR) was up after it entered into a binding joint venture agreement over 40 tenements covering the Central, Warrior and Stockholm areas and surrounding exploration ground of the Charters Towers Gold Project, Queensland with Citigold Corporation (ASX: CTO).
The agreement covers 17 mining leases in the Central area, six in the Warrior area and seven in the Stockholm area, together with a mining lease application, four mineral development licences and five exploration permits for minerals.
“The joint venture over the Central, Warrior and Stockholm tenements gives NMR a disciplined and staged opportunity to assess additional mineralised material in the Charters Towers region,” MD and CEO, Blake Cannavo, said.
“Importantly, NMR retains operational control and will first complete proving-up drilling before deciding whether mining should proceed. If a proceed decision is made, the structure enables costs to be recovered with an 8% margin before the remaining surplus is shared equally with Citigold.”
LDX | US healthcare expansion lifts investor interest
Lumos Diagnostics (ASX: LDX) was popular on HotCopper after it received confirmation that WellStreet Urgent Care will expand the standardised adoption of FebriDx across its network of more than 200 urgent care locations.
FebriDx is a rapid point-of-care test that uses a fingerstick blood sample to aid in the differentiation between bacterial and non-bacterial infection.
“The decision by WellStreet, one of the leading urgent care operators in the US, to standardise FebriDx within its triage protocols across additional locations is a strong endorsement of the product’s clinical value. FebriDx helps physicians make more informed, data-driven decisions at the point of care, supporting both improved patient management and responsible antibiotic stewardship.” CEO, Doug Ward, said.
LOOKING WIDER | ASX slips from 20-day high as housing approvals rebound
Looking wider, the S&P/ASX 200 was lower today, dropping 47.00 points or 0.52% to 8,973.80 after setting a new 20-day high. The bottom performing stocks in this index were Ventia Services Group and Dyno Nobel, down 15.01% and 7.85% respectively. Over the last five days, the index has gained 1.32% and is currently 3.47% off of its 52-week high.
Elsewhere, new data from the Australian Bureau of Statistics (ABS) found that total dwellings approvals rose 5.1% to 17,948.
Private sector houses fell 5.3% to 10,432 while private sector dwellings excluding houses rose 16.6%, to 6,579.
The value of residential building fell 2.8% to $11.06 billion, while the value of non-residential building rose 45.9% to $7.96 billion.
The seasonally adjusted estimate for the number of dwellings approved rose 5.1%, after decreasing 5.2% in August.
The trend estimate for total dwellings approved rose 1.3%, following a 0.4% August rise.
Approvals for total dwellings were mixed: New South Wales (37.3%) and Queensland (28.0%) rose, while Victoria (-28.9%), Tasmania (-25.7%), Western Australia (-8.7%), and South Australia (-3.2%) fell.
Approvals for private sector houses fell across all states: South Australia (-7.8%), Victoria (-6.0%), New South Wales (-5.5%), Queensland (-5.1%), and Western Australia (-4.6%).
That’s Monday’s HotCopper Market Trends, I’m Colin Sandell-Hay - see you for close.
Join the discussion. See what’s trending right now on Australia’s largest stock forum and be part of the conversations that move the markets.
The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.